Bromhexine in chronic bronchitis.
作者信息
Christensen F, Kjer J, Ryskjaer S, Arseth-Hansen P
出版信息
Br Med J. 1970 Oct 10;4(5727):117. doi: 10.1136/bmj.4.5727.117-a.
Abstract
摘要
相似文献
1
Bromhexine in chronic bronchitis.
Br Med J. 1970 Oct 10;4(5727):117. doi: 10.1136/bmj.4.5727.117-a.
2
Expectorant action of bromhexine in chronic obstructive bronchitis.溴己新在慢性阻塞性支气管炎中的祛痰作用。
Br Med J. 1970 Aug 1;3(5717):260-1. doi: 10.1136/bmj.3.5717.260.
3
An assessment in general practice of bromhexine in the treatment of chronic bronchitis.
Practitioner. 1971 Nov;207(241):672-6.
4
A clinical trial of bromhexine.
N Z Med J. 1972 Aug;76(483):73-6.
5
The effects of bromhexine on oxytetracycline penetrance into sputum.
S Afr Med J. 1972 Oct 14;46(41):1512-4.
6
7
The mucolytic agent bromhexine (bisolvon) in chronic lung disease. A double-blind crossover trial.慢性肺病中黏液溶解剂溴己新（必嗽平）：一项双盲交叉试验
Aust N Z J Med. 1971 May;1(2):137-40. doi: 10.1111/j.1445-5994.1971.tb02280.x.
8
A controlled evaluation of bromhexine and orciprenaline in the treatment of chronic bronchitis.
Br J Clin Pract. 1971 Dec;25(12):547-54.
9
Clinical trial of bromhexine in severe chronic bronchitics during winter.氨溴索在冬季重度慢性支气管炎患者中的临床试验。
Thorax. 1972 Jul;27(4):429-32. doi: 10.1136/thx.27.4.429.
10
Mucolytic agents.黏液溶解剂
Br Med J. 1971 Jun 5;2(5761):581-2.
引用本文的文献
1
Drug-based therapeutic strategies for COVID-19-infected patients and their challenges.用于 COVID-19 感染患者的药物治疗策略及其面临的挑战。
Future Microbiol. 2021 Dec;16:1415-1451. doi: 10.2217/fmb-2021-0116. Epub 2021 Nov 23.
2
A reappraisal of the mucoactive activity and clinical efficacy of bromhexine.氨溴索黏液活性及临床疗效的重新评估
Multidiscip Respir Med. 2017 Mar 20;12:7. doi: 10.1186/s40248-017-0088-1. eCollection 2017.
本文引用的文献
1
Effect of bromhexine on ventilatory capacity in patients with a variety of chest diseases.
Lancet. 1969 Nov 22;2(7630):1094-6. doi: 10.1016/s0140-6736(69)90702-8.
Zotero 插件